Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Head European credit strategist says ECB unlikely to be blown off course by Omicron -
During the summer, GlobalCapital surveyed capital markets professionals about how the pandemic has affected their work life, and what they expect to happen next. These are the results
-
Some issuers that have already carried out investor marketing may still seek to issue this year
-
Phoenix Pharma and Reno de Medici both forced into pushing back deals
-
Rates settle after yields plunged on Friday but uncertainty bubbles up
-
High yield hit worst in emerging market bonds sell-off
